Wearable device
Wearable device has been studied in 82 papers since 2017: 4 trials and 24 observational studies in people, 38 reviews; 43 in the past year. The newest paper, Oct 23, 2026: “Comparative Efficacy of eHealth-Based Interventions for Weight Loss in Adults With Overweight or Obesity: A Systematic Review and Network Meta-Analysis”.
82 papers study it28 findingsUpdated
1 new paper in 30 daysSee all 82 papers on wearable device
At a glance
Independent labs found the same change in people. 17 independent labs in 11 countries.
“the change in physical activity was significantly greater in patients with a wearable watch than in those with usual care”
None of its findings points the other way.
- 17 independent labs in 11 countries
- Funders: National Institute for Health Research and others
- 6 of 25 findings with company ties
- Human trial4
- Humans24
- In silico4
Studies in people
1 study gave wearable device to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Increases physical activity2073 [1155-4400] vs 148 [−1261-899] METs-minute/week up: Improves physical function | Randomized trial12 weeks | 39 people82% menmedian age = 73 years, interquartile range = 68-78 yearsPatients aged 60 years or older with cardiovascular disease | Advances in rehabilitation science and practice, May 30, 2025 |
What did studies of wearable device find?
8Studies of wearable device measured 8 outcomes, among them physical activity, heart failure hospitalization and atrial fibrillation detection.
Physical activity
upin humans2
2 studies
Physical activity
upin humans2
Wearable device increases physical activity in humans (2073 [1155-4400] vs 148 [−1261-899] METs-minute/week).
“The change in total physical activity was significantly greater in patients with a wearable watch than in those with usual care (median: 2073 [1155-4400] vs 148 [−1261-899] METs-minute/week; ANCOVA P <.001; ).”
Human trial12 weeksn = 39
Advances in rehabilitation science and practice
Wearable device increases physical activity in humans (older patients with cardiovascular disease) (median: 2073 [1155-4400] vs 148 [-1261-899] METs-minute/week; P < .001).
“the change in physical activity was significantly greater in patients with a wearable watch than in those with usual care”
Human trialolder patients with cardiovascular disease12 weeks82% mensn = 39
Advances in rehabilitation science and practice
Wearable device improves physical activity in humans (small-to-medium effect).
“The use of wearable devices as interventions had a small-to-medium effect on increasing physical activity and daily steps.”
Review
Physical activity interventions for older adults - an overview of systematic reviews
BMC public health
Heart failure hospitalization
downin humans1
1 study
Heart failure hospitalization
downin humans1
Wearable device decreases heart failure hospitalization in structured programs (reductions in heart-failure hospitalization of 18-32%).
“structured heart-failure telemonitoring, associated with reductions in heart-failure hospitalization of 18-32% in structured programs”
Reviewin structured programs
Healthcare (Basel, Switzerland)
Atrial fibrillation detection
upin humans1
1 study
Atrial fibrillation detection
upin humans1
Wearable device improves atrial fibrillation detection in humans.
“Contemporary wearable devices utilizing photoplethysmography and mobile ECG have demonstrated high positive predictive values for AF detection in large-scale studies”
Review
WERABLE TECHNOLOGIES IN ATRIAL FIBRILLATION SCREENING: A NARRATIVE REVIEW
International Journal of Innovative Technologies in Social Science
Mortality
downin humans1RR 0.49
1 study
Mortality
downin humans1RR 0.49
Wearable device decreases mortality in humans (patients with atrial fibrillation) (RR 0.49, 95% CI 0.29-0.85).
“all-cause mortality (RR, 0.49; 95% CI, 0.29-0.85)”
Reviewpatients with atrial fibrillation
Journal of telemedicine and telecare
Diagnostic accuracy
upin humans1
1 study
Diagnostic accuracy
upin humans1
Wearable device improves diagnostic accuracy in humans (for AF detection) (sensitivity and specificity frequently 90–97%).
“achieve high diagnostic accuracy for AF detection (sensitivity and specificity frequently 90–97%)”
Reviewfor AF detection
Quality in Sport
Waist circumference
downin humans1
1 study
Waist circumference
downin humans1
Wearable device decreases waist circumference in humans (overweight or obesity) (MD -5.22 cm, 95% CI -9.03 to -1.40).
“In adults, waist circumference decreased significantly (MD, -5.22 cm; 95% CI, -9.03 to -1.40; P = 0.007)”
Reviewoverweight or obesity
Digital health
BMI
downin humans1
1 study
BMI
downin humans1
Wearable device decreases BMI in humans (overweight or obesity) (MD -0.63 kg/m2, 95% CI -1.01 to -0.25).
“Wearable device interventions significantly reduced BMI overall (mean difference [MD], -0.63 kg/m2; 95% confidence interval [CI], -1.01 to -0.25; P = 0.001)”
Reviewoverweight or obesity
Digital health
Physical function
upin humans1
1 study
Physical function
upin humans1
Wearable device improves physical function in humans.
“The change in the anaerobic threshold was significantly improved in patients with a wearable watch compared with those with usual care (P <.01).”
Human trial12 weeksn = 39
Advances in rehabilitation science and practice
What is wearable device linked with?
18Studies link wearable device with 18 measures, among them heart failure, construct validity and diabetes detection.
Heart failure
upin humans1+87% sensitivity
1 study
Heart failure
upin humans1+87% sensitivity
Wearable device predicts heart failure in humans (heart failure) (87% sensitivity).
“The LINK-HF study predicted HF hospitalization with 87% sensitivity up to six days in advance.”
Reviewheart failure
WEARABLE TECHNOLOGIES IN CARDIOVASCULAR RISK MONITORING: A LITERATURE REVIEW OF CLINICAL EVIDENCE
International Journal of Innovative Technologies in Social Science
Construct validity
upin humans1
1 study
Construct validity
upin humans1
Wearable device is associated with construct validity in humans (non-acute proximal femoral fracture (≥ 15 days since surgery)) (17 of 24 DMOs).
“17 of 24 DMOs showing evidence of construct validity in non-acute PFF patients.”
Humansnon-acute proximal femoral fracture (≥ 15 days since surgery)seven daysn = 505
Scientific reports
Diabetes detection
upin humans1
1 study
Diabetes detection
upin humans1
Wearable device predicts diabetes detection in humans (0.88 AUROC, 0.80 AUPRC).
“with the best algorithm (21-nights) achieving 0.88 Area under ROC (AUROC) and 0.80 Area under Precision Recall (AUPRC)”
Humans21-nights
Communications medicine
Insulin resistance
upin humans1
1 study
Insulin resistance
upin humans1
Wearable device predicts insulin resistance in humans (HOMA-IR cut-off of 2.9) (AUROC = 0.80, sensitivity = 76%, specificity = 84%).
“our multimodal model achieved robust performance (area under the receiver operating characteristic curve (AUROC) = 0.80, sensitivity = 76%, specificity = 84%)”
HumansHOMA-IR cut-off of 2.9n = 1,165
Insulin resistance prediction from wearables and routine blood biomarkers
Nature
Ischemic stroke
downin humans1RR 0.13
1 study
Ischemic stroke
downin humans1RR 0.13
Wearable device lowers the risk of ischemic stroke in humans (patients with atrial fibrillation) (RR 0.13, 95% CI 0.07-0.26).
“ischemic stroke (RR, 0.13; 95% CI, 0.07-0.26)”
Reviewpatients with atrial fibrillation
Journal of telemedicine and telecare
Major adverse cardiovascular events
downin humans1RR 0.66
1 study
Major adverse cardiovascular events
downin humans1RR 0.66
Wearable device lowers the risk of major adverse cardiovascular events in humans (patients with atrial fibrillation) (RR 0.66, 95% CI 0.47-0.93).
“wearable devices uses significantly reduced risks of MACEs (risk ratio [RR], 0.66; 95% confidence interval [CI], 0.47-0.93)”
Reviewpatients with atrial fibrillation
Journal of telemedicine and telecare
Prodromal Parkinson's disease
upin humans1
1 study
Prodromal Parkinson's disease
upin humans1
Wearable device predicts prodromal Parkinson's disease in humans (prodromal Parkinson's disease).
“digital biomarkers based on wearable or portable devices have gradually been applied to identify populations at risk for pPD.”
Reviewprodromal Parkinson's disease
Preprint
Cardiovascular disease
upin humans1
1 study
Cardiovascular disease
upin humans1
Wearable device predicts cardiovascular disease in women.
“Cardiovascular risk stratification showed promising results, though external validation was rare.”
Reviewin women
Archives of gynecology and obstetrics
Blood pressure
mixedin humans1
1 study
Blood pressure
mixedin humans1
Wearable device is associated with blood pressure in humans (validation against gold-standard BP methods).
“Accuracy was moderate to high for diastolic blood pressure, but systolic blood pressure showed greater variability.”
Reviewvalidation against gold-standard BP methods
Archives of gynecology and obstetrics
Atherosclerotic cardiovascular disease risk category
upin humans1
1 study
Atherosclerotic cardiovascular disease risk category
upin humans1
Wearable device predicts atherosclerotic cardiovascular disease risk category in humans (AUC 0.95, 77% sensitivity, 95% specificity).
“A wearable-based model with demographics predicted the ASCVD risk category (≥7.5% vs. <7.5% risk per PREVENT) with an AUC 0.95, 77% sensitivity, and 95% specificity (Table 2).”
Humansmedian follow-up of 4.1 years74% femalesn = 4,193
From Wrist to Risk: Advancing Cardiovascular Prediction Using Wearables
AHA Scientific Sessions 2025 abstract
All 18Fewer
Funding
7 grants since 2016Japan Society for the Promotion of Science¥37.8MNational Institute of Diabetes and Digestive and Kidney Diseases$490KNational Institute on Aging$223K
Japan Society for the Promotion of ScienceUniversity of Tokyo¥4.6M2023–2025
UK Research and InnovationNewcastle University£49.7K2021–2022
National Institute on AgingDeepwave Technologies$223K2020–2023
Japan Society for the Promotion of ScienceHokkaido University¥4.2M2020–2025
National Institute of Diabetes and Digestive and Kidney DiseasesUniversity of Pittsburgh at Pittsburgh$490K2018–2020
Japan Society for the Promotion of ScienceHokkaido University¥25.7M2018–2022
Japan Society for the Promotion of ScienceKyushu University¥3.4M2016–2020
Contains public sector information licensed under the Open Government Licence v3.0.